Evidence map›Paper›PMID 40171822›Full record

ArticleJournal of diabetes2025

Comparative Analysis of Type 2 Diabetes Prevalence and Clinical Profiles in Ethiopia and Nigeria.

Assefa Mulu Baye, Teferi Gedif Fenta, Suvi Karuranga, Ifeyinwa Dorothy Nnakenyi, Ekenechukwu Esther Young, Colin Palmer, Ewan R Pearson, Ifeoma Isabella Ulasi, Adem Y Dawed

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of diabetes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Assefa Mulu BayeDepartment of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-6657-7828
Teferi Gedif FentaDepartment of Pharmaceutics and Social Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Suvi KarurangaEuropean Society for Emergency Medicine, Antwerp, Belgium.
Ifeyinwa Dorothy NnakenyiDepartment of Chemical Pathology, College of Medicine, University of Nigeria & University of Nigeria Teaching Hospital, Enugu, Nigeria.
Ekenechukwu Esther YoungDepartment of Medicine, College of Medicine, University of Nigeria & University of Nigeria Teaching Hospital, Enugu, Nigeria.
Colin PalmerDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, UK.
Ewan R PearsonDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, UK.
Ifeoma Isabella UlasiDepartment of Medicine, College of Medicine, University of Nigeria & University of Nigeria Teaching Hospital, Enugu, Nigeria.
Adem Y DawedDivision of Population Health and Genomics, Ninewells Hospital and School of Medicine, University of Dundee, Dundee, UK.

Funding

National Institute for Health Research 34558a_CRT
6 · The paper itself

Abstract

aimsWe aimed to determine the prevalence of diabetes and the clinical profiles of Type 2 diabetes in Ethiopia and Nigeria.

methodsA community-based cross-sectional study was carried out from November 01, 2020 to October 21, 2021 among 1727 participants using a multistage sampling method. The WHO's STEPs tool was employed. Both fasting and oral glucose tolerance tests were used for screening and American Diabetes Association's (ADA's) diagnostic criteria was used. Stata version 17 was used for analysis. Analysis of Variance (ANOVA) and the Chi-square test were used to compare variables. Significance was declared at a p-value less than 0.05.

resultOf the surveyed participants, 872 (50.5%) were men and the mean age was 44.6 years. The overall prevalence of prediabetes and diabetes was 15.8% and 7.0%, respectively. Impaired fasting glycaemia and glucose tolerance were 11.8% and 11.5%, respectively. The prevalence of newly diagnosed diabetes was 3.4% by fasting and 4.0% by oral glucose tolerance test. Participants with normal blood glucose were younger and had a lower weight, body mass index (BMI), waist circumference, diastolic, and systolic blood pressure, and history of hypertension than those with prediabetes and diabetes.

conclusionIn the present study, there is a notably high diabetes and prediabetes prevalence in the study settings. Individuals with diabetes in Ethiopia compared to Nigeria and the West have different anthropometric and clinical profiles characterized by a young age of onset, leanness, lower BMI, and waist circumference. Hence, the management of diabetes shall be tailored to the unique physiologic and clinical profiles of the population.

Indexed as

Diabetes Mellitus, Type 2Prediabetic StateAdultAgedBlood GlucoseBody Mass IndexCross-Sectional StudiesEthiopiaFemaleGlucose Tolerance TestHumansMaleMiddle AgedNigeriaPrevalenceYoung AdultBlood Glucoseclinical characteristicsdiabetesoral glucose tolerance testsub‐Sahara Africa

Identifiers

PMID40171822
PMCPMC11962519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.